Literature DB >> 24713736

E-cadherin is a specific marker for erythroid differentiation and has utility, in combination with CD117 and CD34, for enumerating myeloblasts in hematopoietic neoplasms.

Robert S Ohgami1, Karen M Chisholm, Lisa Ma, Daniel A Arber.   

Abstract

OBJECTIVES: E-cadherin, epithelial calcium-dependent cell adhesion protein, has been identified as a marker of immature erythroid precursors in recent years. However, the specificity of E-cadherin in bone marrow specimens for erythroblasts vs myeloblasts or other early hematopoietic precursors in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) has not been fully elucidated.
METHODS: We analyzed 105 cases of AML and MDS to evaluate the specificity of E-cadherin.
RESULTS: Of 84 cases of AML, including cases with megakaryocytic, erythroid, monocytic, and granulocytic differentiation, all five acute erythroleukemia cases were positive, as well as one case of megakaryoblastic leukemia that showed coexpression of glycophorin A. In addition, we demonstrate that a panel of three markers, E-cadherin, CD117, and CD34, is effective in identifying lineage-specific myeloblasts in cases of MDS where left-shifted erythroid hyperplasia may complicate morphologic assessment of myeloblasts.
CONCLUSIONS: In marrow specimens, E-cadherin is a useful marker for erythroid differentation.

Entities:  

Keywords:  Acute myeloid leukemia; E-cadherin; Erythroid; Erythroleukemia; Myelodysplastic syndrome

Mesh:

Substances:

Year:  2014        PMID: 24713736     DOI: 10.1309/AJCP8M4QQTAZPGRP

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  7 in total

1.  Congenital immature pure erythroid leukemia with E-cadherin expression.

Authors:  Akihiro Tamura; Suguru Uemura; Atsuro Saito; Saki Okubo; Nanako Nino; Teppei Tahara; Takehito Yokoi; Kenji Kishimoto; Toshiaki Ishida; Daiichiro Hasegawa; Keiichiro Kawasaki; Seiji Yoshimoto; Hideto Nakao; Makiko Yoshida; Yoshiyuki Kosaka
Journal:  Int J Hematol       Date:  2017-05-18       Impact factor: 2.490

Review 2.  Oncogenic Deregulation of Cell Adhesion Molecules in Leukemia.

Authors:  Roland Windisch; Nina Pirschtat; Christian Kellner; Linping Chen-Wichmann; Jörn Lausen; Andreas Humpe; Daniela S Krause; Christian Wichmann
Journal:  Cancers (Basel)       Date:  2019-03-05       Impact factor: 6.639

3.  Pure erythroid leukemia subsequent to acute myelomonocytic leukemia: A case report.

Authors:  Jiamei Ji; Yating Li; Lei Fan; Hua Lu; Xiaoyan Qu
Journal:  Medicine (Baltimore)       Date:  2021-04-16       Impact factor: 1.817

4.  E-Cadherin Expression and Blunted Interferon Response in Blastic Plasmacytoid Dendritic Cell Neoplasm.

Authors:  Luisa Lorenzi; Silvia Lonardi; Donatella Vairo; Andrea Bernardelli; Michela Tomaselli; Mattia Bugatti; Sara Licini; Mariachiara Arisi; Lorenzo Cerroni; Alessandra Tucci; William Vermi; Silvia Clara Giliani; Fabio Facchetti
Journal:  Am J Surg Pathol       Date:  2021-10-01       Impact factor: 6.298

5.  Discrete regulatory modules instruct hematopoietic lineage commitment and differentiation.

Authors:  Grigorios Georgolopoulos; Nikoletta Psatha; Mineo Iwata; Andrew Nishida; Tannishtha Som; Minas Yiangou; John A Stamatoyannopoulos; Jeff Vierstra
Journal:  Nat Commun       Date:  2021-11-23       Impact factor: 17.694

Review 6.  An Algorithmic Immunohistochemical Approach to Define Tumor Type and Assign Site of Origin.

Authors:  Andrew M Bellizzi
Journal:  Adv Anat Pathol       Date:  2020-05       Impact factor: 4.571

7.  Disruption of the BCL11A Erythroid Enhancer Reactivates Fetal Hemoglobin in Erythroid Cells of Patients with β-Thalassemia Major.

Authors:  Nikoletta Psatha; Andreas Reik; Susan Phelps; Yuanyue Zhou; Demetri Dalas; Evangelia Yannaki; Dana N Levasseur; Fyodor D Urnov; Michael C Holmes; Thalia Papayannopoulou
Journal:  Mol Ther Methods Clin Dev       Date:  2018-08-14       Impact factor: 6.698

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.